This site is intended for healthcare professionals
Thalamus, Medulla oblongata under microscope, pink and purple colours
Advances in vasomotor symptom treatments

Transcript: Oestradiol withdrawal and VMS

Last updated: 22nd Jul 2024
Published: 22nd Jul 2024

Dr Lisa Larkin

All transcripts are created from interview footage and directly reflect the content of the interview at the time. The content is that of the speaker and is not adjusted by Medthority.

So menopause is a time when we know that ovarian function declines and we see declining oestrogen, and this is the time when women develop vasomotor symptoms. We have known for centuries that oestrogen plays a key role in the development of vasomotor symptoms, and we've known that giving oestrogen back helps vasomotor symptoms. We've known that for a long time. What we've also known though, is that all women go through menopause, all women have declining estradiol levels, but not all women experience vasomotor symptoms. And so this has led us to question, is oestrogen the entire cause of the vasomotor symptoms? And more recently we've learned through great basic science research that it is in fact more complicated than just oestrogen. Oestrogen certainly plays a role, but there's more to the story.

View the video

Complete the form below to receive our regular round-up of the latest clinical news and medical education resources on Medthority, straight to your inbox.

* = required information 

 

By providing your email address, you are opting in to receive our monthly newsletter.

By submitting this form you agree to our Terms of Use and Privacy Policy. You can withdraw your consent at any time by clicking the ‘unsubscribe’ link found at the bottom of every email.

Welcome:

This content has been developed independently by Medthority who previously received educational funding in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.